Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

More Skin in the Game: Screening for Skin Cancer in IBD Patients

More Skin in the Game: Screening for Skin Cancer in IBD Patients Digestive Diseases and Sciences (2018) 63:2497–2499 https://doi.org/10.1007/s10620-018-5136-y EDITORIAL 1 1 Seema A. Patil  · Raymond K. Cross Published online: 4 June 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Optimal care of patients with inflammatory bowel disease Melanoma rates are increasing annually, with the Amer- (IBD), though usually discussed in terms of diagnostic test- ican Cancer Society estimating there will be 91,270 new ing, procedures, and therapeutic interventions, also requires cases and 9,320 deaths attributed to melanoma in 2018. close attention to preventive care and health maintenance. NMSC is the most common of all types of cancer, with Healthcare maintenance is essential since the medications an estimated 3.3 million Americans diagnosed each year. used for treatment of IBD are accompanied by often prevent- Eighty and twenty percent are basal cell and squamous cell able adverse effects, and also because many IBD patients cancers, respectively. Nevertheless, death from these can- consider their gastroenterologist to be their primary care cers is not common. About 2000 people die from NMSC provider. in the USA each year [4]. No randomized controlled stud- Among all types of cancers, skin cancers appear to among ies have been conducted to establish the efficacy of skin the most increased http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Digestive Diseases and Sciences Springer Journals

More Skin in the Game: Screening for Skin Cancer in IBD Patients

Patil, Seema; Cross, Raymond
Digestive Diseases and Sciences , Volume 63 (10) – Jun 4, 2018
Download PDF
3 pages

Loading next page...
 
/lp/springer_journal/more-skin-in-the-game-screening-for-skin-cancer-in-ibd-patients-M4jwfV11OE
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Gastroenterology; Hepatology; Oncology; Transplant Surgery; Biochemistry, general
ISSN
0163-2116
eISSN
1573-2568
DOI
10.1007/s10620-018-5136-y
pmid
29869124
Publisher site
See Article on Publisher Site

Abstract

Digestive Diseases and Sciences (2018) 63:2497–2499 https://doi.org/10.1007/s10620-018-5136-y EDITORIAL 1 1 Seema A. Patil  · Raymond K. Cross Published online: 4 June 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Optimal care of patients with inflammatory bowel disease Melanoma rates are increasing annually, with the Amer- (IBD), though usually discussed in terms of diagnostic test- ican Cancer Society estimating there will be 91,270 new ing, procedures, and therapeutic interventions, also requires cases and 9,320 deaths attributed to melanoma in 2018. close attention to preventive care and health maintenance. NMSC is the most common of all types of cancer, with Healthcare maintenance is essential since the medications an estimated 3.3 million Americans diagnosed each year. used for treatment of IBD are accompanied by often prevent- Eighty and twenty percent are basal cell and squamous cell able adverse effects, and also because many IBD patients cancers, respectively. Nevertheless, death from these can- consider their gastroenterologist to be their primary care cers is not common. About 2000 people die from NMSC provider. in the USA each year [4]. No randomized controlled stud- Among all types of cancers, skin cancers appear to among ies have been conducted to establish the efficacy of skin the most increased

Journal

Digestive Diseases and Sciences – Springer Journals

Published: Jun 4, 2018

References

  • Optimal management of skin cancer in immunosuppressed patients
    Brin, L; Zubair, AS; Brewer, JD
  • Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease
    Long, MD; Martin, CF; Pipikin, CA
  • Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis
    Singh, S; Nagpal, SJ; Murad, MH
  • Cancer statistics, 2018
    Siegel, RL; Miller, KD; Jemal, A
  • Clinical whole-body skin examination reduces the incidence of thick melanomas
    Aitken, JF; Elwood, M; Baade, PD
  • Screening for Skin Cancer in Adults
    Wernli, Karen J.; Henrikson, Nora B.; Morrison, Caitlin C.; Nguyen, Matthew; Pocobelli, Gaia; Blasi, Paula R.
  • ACG clinical guideline: preventive care in inflammatory bowel disease
    Farraye, FA; Melmed, GY; Lichtenstein, GR; Kane, SV
  • Analysis of trends in geographic distribution and density of US dermatologists
    Glazer, AM; Farberg, AS; Winkelmann, RR
  • Analysis of trends in geographic distribution of US dermatology workforce density
    Glazer, AM; Rigel, DS
  • Teledermatology for the diagnosis and management of skin cancer: a systematic review
    Finnane, A; Dallest, K; Janda, M; Soyer, HP
  • Efficacy of skin self-examination for the early detection of melanoma
    Hamidi, R; Peng, D; Cockburn, M